Corporate News

Administration of NuPharm

26 April 2017

Quantum Pharma Plc (AIM: QP.), the service-led niche pharmaceutical developer, manufacturer and supplier, announces that following the cessation of trading at NuPharm Laboratories Limited ('NuPharm') in January, NuPharm was placed into administration earlier today. In accordance with paragraph (g) of Schedule 2 of the AIM Rules for Companies, Quantum confirms that Chris Rigg, CEO, was also a director of NuPharm when it was placed into administration.


For further information:

Quantum Pharma Plc  
Chris Rigg, Chief Executive Officer Tel: +44 (0) 1207 279 404
Gerard Murray, Chief Financial Officer
N+1 Singer
(Nominated Advisor & Broker)
Tel: +44 (0) 20 7496 3000
Sandy Fraser / Nick Owen / James White
Media enquiries:  
Henry Harrison-Topham Tel: +44 (0) 20 7466 5000


Notes to Editors

Quantum Pharma is a service-led, niche pharmaceutical developer, manufacturer and supplier to the retail pharmacy, pharmaceutical wholesale, hospital, homecare and care home markets. Quantum Pharma operates through three divisions - Specials, Niche Pharmaceuticals and Medication Adherence - offering a portfolio of innovative and complementary products and services.

For further information, please visit


back to top

back to Takeover Code


Quantum Pharmaceuticals
UL Medicines
Quantum Aseptics
PERN Consumer Products